您好，欢迎来到试剂仪器网！ [登录] [免费注册]
试剂仪器网
发布求购
位置：首页 > 产品库 > HDAC1-IN-3
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
HDAC1-IN-3
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
HDAC1-IN-3图片
包装与价格：
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
HDAC1-IN-3 是一种有效的Pf HDAC1抑制剂。HDAC1-IN-3 在野生型和耐多药寄生虫菌株中均显示出抗疟活性。HDAC1-IN-3 对寄生虫所有生命周期显示出显著的体内杀伤作用。
生物活性

HDAC1-IN-3 is a potentPfHDAC1inhibitor. HDAC1-IN-3 shows antimalarial activity in wild-type and multidrug-resistantparasitestrains. HDAC1-IN-3 shows a significant in vivo killing effect against all life cycles of parasites[1].

IC50& Target

HDAC1

2.2 nM (IC50)

HDAC2

5.1 nM (IC50)

HDAC3

5.2 nM (IC50)

HDAC6

85.5 nM (IC50)

HDAC8

29.9 nM (IC50)

Plasmodium

 

体外研究
(In Vitro)

HDAC1-IN-3 (compound JX35) shows antimalarial activity with IC50s of 1.26 nM and 1.61 nM for wild-typePlasmodium falciparum (P. falciparum)parasite 3D7 and chloroquine-resistantP. falciparumparasite Dd2, respectively[1].
HDAC1-IN-3 (10 μM; 72 h) shows low cytotoxicity with IC50s of 1.02 μM and 1.21 μM for HepG2, 293T cells, respectively[1].
HDAC1-IN-3 (72 h) shows no cross-resistance with clinical antimalarial drugs with IC50s of 3.06, 2.18, 5.85 nM for GB4, C2A, CP286, respectively[1].
HDAC1-IN-3 (10, 30, 60, 100 nM; 3, 6, 12, 24 h) shows antimalarial activity in a time- and dose-dependent manner with asynchronous 3D7 parasites[1].
HDAC1-IN-3 (40 nM, 4 days;P. falciparum3D7 cells) shows the killing effects of JX35 onP. falciparumparasites during asexual reproduction stages might be related to the inhibition of schizont growth and reinvasion of RBCs (red blood cells)[1].
HDAC1-IN-3 (5, 20 nM; 4 h) inhibits the expression of Pf HDAC against ART (artemisinin)-resistant parasite strains[1].
HDAC1-IN-3 reduces the inhibition of hHDACs with IC50s of 2.2, 5.1, 5.2, 85.5, 29.9 nM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, respectively[1].

Cell Cytotoxicity Assay[1]

Cell Line:HepG2, 293T cells
Concentration:10 μM
Incubation Time:72 h
Result:Showed low cytotoxicity with IC50s of 1.02 μM and 1.21 μM for HepG2, 293T cells, respectively.

Western Blot Analysis[1]

Cell Line:P. falciparum3D7 cells
Concentration:5, 20 nM
Incubation Time:4 h
Result:Inhibited the expression of Pf HDAC against ART (artemisinin)-resistant parasite strains.
体内研究
(In Vivo)

HDAC1-IN-3 (30, 60, 90 mg/kg; i.p.; once daily for 5 days) shows acceptable therapeutic efficacy and safety[1].
HDAC1-IN-3 (5 mg/kg; i.p.) shows good pharmacokinetic properties[1].
Pharmacokinetic Parameters of HDAC1-IN-3 in Female BALB/c mice[1].

parameterJX35
Cmax(ng/mL)539
Tmax(h)0.25
AUClast(h·ng/mL)638
AUCinf(h·ng/mL)640
t1/2(h)0.91
CLZ/F(L/h/kg)7.81
VZ/F(L/kg)10.20
Female BALB/c mice; 5 mg/kg; i.p.

Animal Model:6-8 weeks, BALB/c female mice[1]
Dosage:30, 60, 90 mg/kg
Administration:I.p., once daily for 5 days
Result:Showed acceptable therapeutic efficacy and safety.
Animal Model:6-8 weeks, female BALB/c mice[1]
Dosage:5 mg/kg
Administration:I.p.
Result:Showed good pharmacokinetic properties.
分子量

453.92

Formula

C22H24ClN7O2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.